SEC Form 4 · accession 0001179110-16-031325
YIELD10 BIOSCIENCE, INC. · YTEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H Shaulson
Director
Period of report
Nov 4, 2016
Accepted (ET)
Nov 8, 2016 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001121702
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 4, 2016 | F | 49,080 | $0.44 | D | 320,514 | D | |
| Common StockF2 | holding | — | — | — | 14,695 | I | By 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $0.44 | Nov 4, 2016 | A | 400,000 | A | — | Dec 19, 2023 | Common Stock | 400,000 | 400,000 | D |
| Stock Option (right to buy)F3,F4 | $0.44 | Nov 4, 2016 | A | 350,000 | A | — | Dec 19, 2023 | Common Stock | 350,000 | 350,000 | D |
Explanation of responses
- F1Represents shares withheld in payment of witholding taxes upon vesting of RSUs granted 4/1/15.
- F2Shares acquired as Company matching contributions under the Metabolix, Inc. 401(k) Plan.
- F3This stock option will become exercisable upon the effectiveness of the release executed by Mr. Shaulson in connection with his separation agreement with the Issuer.
- F4This stock option is subject to and contingent upon shareholder approval of the amendments to the Issuer's 2014 Stock Option and Incentive Plan adopted by the Issuer's Board of Directors on October 31, 2016.